Skip to main content
Log in

Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients

  • Original Article
  • Published:
Journal of Anesthesia Aims and scope Submit manuscript

Abstract

Purpose

Proinflammatory and anti-inflammatory cytokines may play a pivotal role in cerebral inflammation, which is implicated in the development of brain injury. Systemic cytokine release is mediated by the sympathetic nervous system and catecholamines. The aim of this study was to investigate which parameters, among plasma levels of interleukin-1β (IL-1β), interleukin-6 (IL-6), interleukin-10 (IL-10), and tumor necrosis factor alpha (TNF-α) and the levels of the catecholamines, epinephrine and norepinephrine, contribute to the clinical outcome in acute stroke patients.

Methods

Thirty-seven acute stroke patients (ischemic, n = 19; hemorrhagic, n = 18) were enrolled. All of them were admitted to our hospital within 8 h after stroke onset. Neurological status was evaluated by a modified National Institute of Health Stroke Scale (mNIHSS) on admission and by a modified Rankin Scale (mRS) at 1 month. An mRS score of 3 or more at 1 month was considered to indicate poor outcome. Serum samples for the cytokine and catecholamine measurements were collected on admission. Plasma levels of IL-1β, IL-6, IL-10, and TNF-α were determined by an enzyme-linked immunosorbent assay (ELISA) method and epinephrine and norepinephrine concentrations were determined by high-performance liquid chromatography with electrochemical detection (HPLC-EC).

Results

In the ischemic stroke patients, poor outcome was noted in 9 (47%). There were no significant differences in cytokine or catecholamine concentrations between patients with poor and good outcomes, and there was no association between clinical outcome and cytokine and catecholamine concentrations. In the hemorrhagic stroke patients, poor outcome was noted in 10 (56%). IL-6 and IL-10 levels were higher in patients with poor outcome. On logistic regression analysis, higher values of IL-6 were significantly associated with clinical outcome at 1 month (odds ratio [OR], 1.25; 95% confidence interval [CI], 1.02–1.54).

Conclusion

In ischemic stroke, plasma cytokines and catecholamines were not predictors of neurological outcome at 1 month. In hemorrhagic stroke, high levels of IL-6 in the early phase indicated a poor neurological outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Becker KJ. Inflammation and acute stoke. Curr Opin Neurol. 1998;11:45–49.

    Article  PubMed  CAS  Google Scholar 

  2. Vila N, Filella X, Deulofeu R, Ascaso C, Abellana R, Chamorro A. Cytokine-induced inflammation and long-term stroke functional outcome. J Neurol Sci. 1999;162:185–188.

    Article  PubMed  CAS  Google Scholar 

  3. Woiciechowsky C, Schoning B, Lanksch WR, Volk HD, Docke WD. Mechanisms of brain-mediated systemic anti-inflammatory syndrome causing immunodepression. J Mol Med. 1999;77:769–780.

    Article  PubMed  CAS  Google Scholar 

  4. Liu T, McDonnell PC, Young PR, White RF, Siren AL, Hallenbeck JM, Barone FC, Feuerstein GZ. Interleukin 1β mRNA expression in ischemic rat cortex. Stroke. 1993;24:1746–1752.

    PubMed  CAS  Google Scholar 

  5. Wang X, Yue T-L, Young PR, Barone FC, Feuerstein GZ. Expression of interleukin-6, c-fos and zif268 mRNA in rat ischemic cortex. J Cereb Blood Flow Metab. 1995;15:166–171.

    PubMed  CAS  Google Scholar 

  6. Liu T, Clark RK, McDonnell PC, Young PR, White RF, Barone FC, Feuerstein GZ. Tumor necrosis factor-α in ischemic neurons. Stroke. 1994;25:1481–1488.

    PubMed  CAS  Google Scholar 

  7. Fassbender K, Rossol S, Kammer T, Daffertshofer M, Wirth S, Dollman M, Hennerici M. Proinflammatory cytokines in serum of patients with acute cerebral damage and outcome of disease. J Neurol Sci. 1994;122:135–139.

    Article  PubMed  CAS  Google Scholar 

  8. Dziedzic T, Bartus S, Klimkowicz A, Motyl M, Slowik A, Szczudlik A. Intracranial hemorrhage triggers interleukin-6 and interleukin-10 release in blood. Stroke. 2002;33:2334–2335.

    Article  PubMed  CAS  Google Scholar 

  9. Smith CJ, Emsley HCA, Gavin CM, Georgiou RF, Vail A, Barberan EM, Zoppo GJ, Hallenbeck JM, Rothwell NJ, Hopkins SJ, Tyrrell PJ. Peak plasma interleukin-6 and other peripheral markers of inflammation in the first week of ischemic stoke correlate with brain infarct volume, stroke severity and long-term outcome. BMC Neurol. 2004;15:4:2.

    Article  Google Scholar 

  10. Tarkowski E, Rosengren L, Blomstrand C, Wikkelso C, Jensen C, Ekholm S, Tarkowski A. Intrathecal release of pro-and anti-inflammatory cytokines during stroke. Clin Exp Immunol. 1997;110:492–499.

    Article  PubMed  CAS  Google Scholar 

  11. Perini F, Morra M, Alecci M, Galloni E, Marchi M, Toso V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute stroke patients. Neurol Sci. 2001;22:289–296.

    Article  PubMed  CAS  Google Scholar 

  12. Vila N, Castillo J, Davalos A, Esteve A, Planas A, Chamorro A. Levels of anti-inflammatory cytokines and neurological worsening in acute ischemic stroke. Stroke. 2003;34:671–675.

    Article  PubMed  CAS  Google Scholar 

  13. Marz P, Cheng JG, Gadient R, Patterson P, Stoyan T, Otten U, Rose-John S. Sympathetic neurons can produce and respond to IL-6. Proc Natl Acad Sci U S A. 1998;95:3251–3256.

    Article  PubMed  CAS  Google Scholar 

  14. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schoening B, Gloeckner F, Lanksch WR, Volk HD, Doecke WD. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808–813.

    Article  PubMed  CAS  Google Scholar 

  15. Myers MG, Norris JW, Hachinski VC, Sole MJ. Plasma norepinephrine in stroke. Stroke. 1981;12:200–204.

    PubMed  CAS  Google Scholar 

  16. Naredi S, Lambert G, Eden E, Zall S, Runnerstam M, Rydenhag B, Friberg P. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2001;31:901–906.

    Google Scholar 

  17. Benedict CR, Phil D, Loach AB. Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke. 1978;9:237–244.

    PubMed  CAS  Google Scholar 

  18. Meyer JS, Stoica E, Pascu I, Shimazu K, Hartmann A. Catecholamine concentrations in CSF and plasma of patients with cerebral infarction and hemorrhage. Brain. 1973;96:277–288.

    Article  PubMed  CAS  Google Scholar 

  19. Baron JC. Perfusion thresholds in human ischemia: historical perspective and therapeutic implications. Cerebrovasc Dis. 2001;11(Suppl 1):2–8.

    Article  PubMed  Google Scholar 

  20. Lyden PD, Lu M, Levine SR, Brott TG, Broderick J, the NINDS rtPA Stroke Study Group. A modified National Institutes of Health Stroke Scale for use in stroke clinical trials. Preliminary reliability and validity. Stroke. 2001;32:1310–1317.

    PubMed  CAS  Google Scholar 

  21. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJA, van Gijin J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19:604–607.

    PubMed  Google Scholar 

  22. Vila N, Castillo J, Davalos A, Esteve A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2003;31:2325–2329.

    Google Scholar 

  23. McKeating EG, Andrews PJD, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after brain injury. Br J Anaesth. 1997;78:520–523.

    PubMed  CAS  Google Scholar 

  24. Mazzotta G, Sarchielli P, Caso V, Paciaroni M, Floridi A, Gallai V. Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur J Neurol. 2004;11:377–381.

    Article  PubMed  CAS  Google Scholar 

  25. Intiso D, Zarrelli MM, Lagioia G, Rienzo FD, Ambrosio CCD, Simone P, Tonali P, Cioffi RP. Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol Sci. 2003;24:390–396.

    Article  Google Scholar 

  26. Ferrarese C, Mascarucci P, Zoia C, Cavarretta R, Frigo M, Begni B, Sarinella F, Frattola L, Simoni MGD. Increased cytokine release from peripheral blood cells after acute stroke. J Cereb Blood Flow Metab. 1999;19:1004–1009.

    Article  PubMed  CAS  Google Scholar 

  27. Planz G, Wiethold G, Appel E, Bohmer D, Palm D, Grobecker H. Correlation between increased dopamine-beta-hydroxylase activity and catecholamine concentration in plasma: determination of acute changes in sympathetic activity in man. Eur J Clin Pharmacol. 1975;8:181–188.

    Article  PubMed  CAS  Google Scholar 

  28. Cryer PE. Physiology and pathophysiology of the human sympathoadrenal neuroendocrine system. N Engl J Med. 1980;303:436–444.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Oto, J., Suzue, A., Inui, D. et al. Plasma proinflammatory and anti-inflammatory cytokine and catecholamine concentrations as predictors of neurological outcome in acute stroke patients. J Anesth 22, 207–212 (2008). https://doi.org/10.1007/s00540-008-0639-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00540-008-0639-x

Key words

Navigation